Invention Grant
- Patent Title: Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
-
Application No.: US17025371Application Date: 2020-09-18
-
Publication No.: US11358711B2Publication Date: 2022-06-14
- Inventor: Thomas H. Graham , Tao Yu , Yonglian Zhang , John A. McCauley
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent John C. Todaro
- Main IPC: A61K31/5365
- IPC: A61K31/5365 ; B64C27/48 ; B64C11/08 ; A61P31/18 ; A61K31/18 ; A61K31/407 ; A61K31/4188 ; A61K31/4439 ; A61K31/4985 ; A61K31/519 ; A61K31/553 ; A61K31/7076 ; C07D498/16 ; C07D498/22 ; C12N15/113
Abstract:
The present invention relates to Tetracyclic Heterocycle Compounds of Formula and pharmaceutically acceptable salts or prodrug thereof, wherein A, X, R1, R2, R3 and Ware as defined herein. The present invention also relates to compositions comprising at least one Tetracyclic Heterocycle Compound, and methods of using the Tetracyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.
Public/Granted literature
- US20210009262A1 TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS Public/Granted day:2021-01-14
Information query
